PKD1 Duplicated regions limit clinical Utility of Whole Exome Sequencing for Genetic Diagnosis of Autosomal Dominant Polycystic Kidney Disease

Hamad Ali, Fahd Al-Mulla, Naser Hussain, Medhat Naim, Akram M. Asbeutah, Ali AlSahow, Mohamed Abu-Farha, Jehad Abubaker, Ashraf Al Madhoun, Sajjad Ahmad, Peter C Harris

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is an inherited monogenic renal disease characterised by the accumulation of clusters of fluid-filled cysts in the kidneys and is caused by mutations in PKD1 or PKD2 genes. ADPKD genetic diagnosis is complicated by PKD1 pseudogenes located proximal to the original gene with a high degree of homology. The next generation sequencing (NGS) technology including whole exome sequencing (WES) and whole genome sequencing (WGS), is becoming more affordable and its use in the detection of ADPKD mutations for diagnostic and research purposes more widespread. However, how well does NGS technology compare with the Gold standard (Sanger sequencing) in the detection of ADPKD mutations? Is a question that remains to be answered. We have evaluated the efficacy of WES, WGS and targeted enrichment methodologies in detecting ADPKD mutations in the PKD1 and PKD2 genes in patients who were clinically evaluated by ultrasonography and renal function tests. Our results showed that WES detected PKD1 mutations in ADPKD patients with 50% sensitivity, as the reading depth and sequencing quality were low in the duplicated regions of PKD1 (exons 1–32) compared with those of WGS and target enrichment arrays. Our investigation highlights major limitations of WES in ADPKD genetic diagnosis. Enhancing reading depth, quality and sensitivity of WES in the PKD1 duplicated regions (exons 1–32) is crucial for its potential diagnostic or research applications.

Original languageEnglish (US)
Article number4141
JournalScientific reports
Volume9
Issue number1
DOIs
StatePublished - Dec 1 2019

Fingerprint

Exome
Autosomal Dominant Polycystic Kidney
Mutation
Genome
Kidney
Reading
Exons
Genes
Technology
Cyst Fluid
Pseudogenes
Research
Ultrasonography

ASJC Scopus subject areas

  • General

Cite this

PKD1 Duplicated regions limit clinical Utility of Whole Exome Sequencing for Genetic Diagnosis of Autosomal Dominant Polycystic Kidney Disease. / Ali, Hamad; Al-Mulla, Fahd; Hussain, Naser; Naim, Medhat; Asbeutah, Akram M.; AlSahow, Ali; Abu-Farha, Mohamed; Abubaker, Jehad; Al Madhoun, Ashraf; Ahmad, Sajjad; Harris, Peter C.

In: Scientific reports, Vol. 9, No. 1, 4141, 01.12.2019.

Research output: Contribution to journalArticle

Ali, H, Al-Mulla, F, Hussain, N, Naim, M, Asbeutah, AM, AlSahow, A, Abu-Farha, M, Abubaker, J, Al Madhoun, A, Ahmad, S & Harris, PC 2019, 'PKD1 Duplicated regions limit clinical Utility of Whole Exome Sequencing for Genetic Diagnosis of Autosomal Dominant Polycystic Kidney Disease', Scientific reports, vol. 9, no. 1, 4141. https://doi.org/10.1038/s41598-019-40761-w
Ali, Hamad ; Al-Mulla, Fahd ; Hussain, Naser ; Naim, Medhat ; Asbeutah, Akram M. ; AlSahow, Ali ; Abu-Farha, Mohamed ; Abubaker, Jehad ; Al Madhoun, Ashraf ; Ahmad, Sajjad ; Harris, Peter C. / PKD1 Duplicated regions limit clinical Utility of Whole Exome Sequencing for Genetic Diagnosis of Autosomal Dominant Polycystic Kidney Disease. In: Scientific reports. 2019 ; Vol. 9, No. 1.
@article{b06e2427b32542a091f0a0fcc41946ca,
title = "PKD1 Duplicated regions limit clinical Utility of Whole Exome Sequencing for Genetic Diagnosis of Autosomal Dominant Polycystic Kidney Disease",
abstract = "Autosomal dominant polycystic kidney disease (ADPKD) is an inherited monogenic renal disease characterised by the accumulation of clusters of fluid-filled cysts in the kidneys and is caused by mutations in PKD1 or PKD2 genes. ADPKD genetic diagnosis is complicated by PKD1 pseudogenes located proximal to the original gene with a high degree of homology. The next generation sequencing (NGS) technology including whole exome sequencing (WES) and whole genome sequencing (WGS), is becoming more affordable and its use in the detection of ADPKD mutations for diagnostic and research purposes more widespread. However, how well does NGS technology compare with the Gold standard (Sanger sequencing) in the detection of ADPKD mutations? Is a question that remains to be answered. We have evaluated the efficacy of WES, WGS and targeted enrichment methodologies in detecting ADPKD mutations in the PKD1 and PKD2 genes in patients who were clinically evaluated by ultrasonography and renal function tests. Our results showed that WES detected PKD1 mutations in ADPKD patients with 50{\%} sensitivity, as the reading depth and sequencing quality were low in the duplicated regions of PKD1 (exons 1–32) compared with those of WGS and target enrichment arrays. Our investigation highlights major limitations of WES in ADPKD genetic diagnosis. Enhancing reading depth, quality and sensitivity of WES in the PKD1 duplicated regions (exons 1–32) is crucial for its potential diagnostic or research applications.",
author = "Hamad Ali and Fahd Al-Mulla and Naser Hussain and Medhat Naim and Asbeutah, {Akram M.} and Ali AlSahow and Mohamed Abu-Farha and Jehad Abubaker and {Al Madhoun}, Ashraf and Sajjad Ahmad and Harris, {Peter C}",
year = "2019",
month = "12",
day = "1",
doi = "10.1038/s41598-019-40761-w",
language = "English (US)",
volume = "9",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - PKD1 Duplicated regions limit clinical Utility of Whole Exome Sequencing for Genetic Diagnosis of Autosomal Dominant Polycystic Kidney Disease

AU - Ali, Hamad

AU - Al-Mulla, Fahd

AU - Hussain, Naser

AU - Naim, Medhat

AU - Asbeutah, Akram M.

AU - AlSahow, Ali

AU - Abu-Farha, Mohamed

AU - Abubaker, Jehad

AU - Al Madhoun, Ashraf

AU - Ahmad, Sajjad

AU - Harris, Peter C

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Autosomal dominant polycystic kidney disease (ADPKD) is an inherited monogenic renal disease characterised by the accumulation of clusters of fluid-filled cysts in the kidneys and is caused by mutations in PKD1 or PKD2 genes. ADPKD genetic diagnosis is complicated by PKD1 pseudogenes located proximal to the original gene with a high degree of homology. The next generation sequencing (NGS) technology including whole exome sequencing (WES) and whole genome sequencing (WGS), is becoming more affordable and its use in the detection of ADPKD mutations for diagnostic and research purposes more widespread. However, how well does NGS technology compare with the Gold standard (Sanger sequencing) in the detection of ADPKD mutations? Is a question that remains to be answered. We have evaluated the efficacy of WES, WGS and targeted enrichment methodologies in detecting ADPKD mutations in the PKD1 and PKD2 genes in patients who were clinically evaluated by ultrasonography and renal function tests. Our results showed that WES detected PKD1 mutations in ADPKD patients with 50% sensitivity, as the reading depth and sequencing quality were low in the duplicated regions of PKD1 (exons 1–32) compared with those of WGS and target enrichment arrays. Our investigation highlights major limitations of WES in ADPKD genetic diagnosis. Enhancing reading depth, quality and sensitivity of WES in the PKD1 duplicated regions (exons 1–32) is crucial for its potential diagnostic or research applications.

AB - Autosomal dominant polycystic kidney disease (ADPKD) is an inherited monogenic renal disease characterised by the accumulation of clusters of fluid-filled cysts in the kidneys and is caused by mutations in PKD1 or PKD2 genes. ADPKD genetic diagnosis is complicated by PKD1 pseudogenes located proximal to the original gene with a high degree of homology. The next generation sequencing (NGS) technology including whole exome sequencing (WES) and whole genome sequencing (WGS), is becoming more affordable and its use in the detection of ADPKD mutations for diagnostic and research purposes more widespread. However, how well does NGS technology compare with the Gold standard (Sanger sequencing) in the detection of ADPKD mutations? Is a question that remains to be answered. We have evaluated the efficacy of WES, WGS and targeted enrichment methodologies in detecting ADPKD mutations in the PKD1 and PKD2 genes in patients who were clinically evaluated by ultrasonography and renal function tests. Our results showed that WES detected PKD1 mutations in ADPKD patients with 50% sensitivity, as the reading depth and sequencing quality were low in the duplicated regions of PKD1 (exons 1–32) compared with those of WGS and target enrichment arrays. Our investigation highlights major limitations of WES in ADPKD genetic diagnosis. Enhancing reading depth, quality and sensitivity of WES in the PKD1 duplicated regions (exons 1–32) is crucial for its potential diagnostic or research applications.

UR - http://www.scopus.com/inward/record.url?scp=85062764939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062764939&partnerID=8YFLogxK

U2 - 10.1038/s41598-019-40761-w

DO - 10.1038/s41598-019-40761-w

M3 - Article

C2 - 30858458

AN - SCOPUS:85062764939

VL - 9

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 4141

ER -